Tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma patients without measurable disease at infusion.
暂无分享,去创建一个
H. Holte | U. Jäger | M. Bishop | S. Schuster | J. Westin | E. Waller | P. Borchmann | J. McGuirk | I. Fleury | L. Pacaud | R. Awasthi | Ö. Anak | R. Maziarz | Christopher del Corral | R. Tiwari | V. Romanov | J. Mcguirk